Skip to main content

Green Cross Corp/South Korea

GC Biopharma Corp, formerly Green Cross Corp, is a South Korean biopharmaceutical company specializing in plasma-derived therapeutics and vaccines. The company manufactures plasma protein therapeutics including human serum albumin and immunoglobulins, influenza vaccines, chickenpox vaccines, and rare disease treatments. Main revenue drivers comprise domestic and export sales of plasma therapeutics, seasonal flu vaccines, diagnostic kits, and prescription pharmaceuticals. GC Biopharma serves hospitals, public health authorities, prescription pharmacies, and clinical medical centers across South Korea, North America, and emerging international markets. The company holds a market-leading domestic position as South Korea's premier supplier of plasma products and vaccines. Headquartered in Yongin, Gyeonggi Province, South Korea, it is listed on the Korea Exchange.

2 of the funds FundTelligence covers report a position in Green Cross Corp/South Korea.

Sector
Health Care
Country
South Korea
Funds holding it
2

Funds holding Green Cross Corp/South Korea

Loading...